Linbo Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 11
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 8
- Oncology 29
- Cancer Cells and Metastasis 7
- Co-authors
- Jichun Zhou (56 shared papers)Yongxia Chen (33 shared papers)Cong Chen (15 shared papers)Zhaoqing Li (12 shared papers)Hanchu Xiong (14 shared papers)Yulu Zhou (8 shared papers)Shuduo Xie (19 shared papers)Jianguo Shen (26 shared papers)
- Journals
- Oncotarget (8 papers)Biomarker Research (5 papers)Biomedical Optics Express (4 papers)PLoS ONE (4 papers)OncoTargets and Therapy (4 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Linbo Wang
136 papers receiving 4.5k citations
Linbo Wang's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.3k
- Oncology 757
- Pulmonary and Respiratory Medicine 894
- Molecular Biology 1.9k
- Complementary and alternative medicine 200
Countries citing papers authored by Linbo Wang
This map shows the geographic impact of Linbo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linbo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linbo Wang more than expected).
Fields of papers citing papers by Linbo Wang
This network shows the impact of papers produced by Linbo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linbo Wang. The network helps show where Linbo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Linbo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer Hit paper breakdown → | 2021 | 304 |
| 2 | 2020 | 218 | |
| 3 | 2019 | 214 | |
| 4 | 2017 | 210 | |
| 5 | Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities Hit paper breakdown → | 2022 | 205 |
| 6 | 2017 | 169 | |
| 7 | 2020 | 160 | |
| 8 | 2022 | 143 | |
| 9 | 2019 | 138 | |
| 10 | 2004 | 116 | |
| 11 | 2021 | 114 | |
| 12 | 2015 | 110 | |
| 13 | 2020 | 89 | |
| 14 | 2005 | 76 | |
| 15 | 2016 | 72 | |
| 16 | 2022 | 69 | |
| 17 | 2003 | 66 | |
| 18 | 2012 | 65 | |
| 19 | 2022 | 62 | |
| 20 | 2007 | 59 |
About Linbo Wang
Linbo Wang is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 148 papers that have together received 4.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), RNA modifications and cancer (9 papers), Kruppel-like factors research (9 papers), Cancer-related gene regulation (9 papers), Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (8 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (757 citations), Pulmonary and Respiratory Medicine (894 citations), Molecular Biology (1.9k citations) and Complementary and alternative medicine (200 citations). Linbo Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jichun Zhou, Yongxia Chen, Cong Chen, Zhaoqing Li, Hanchu Xiong, Yulu Zhou, Shuduo Xie, Jianguo Shen, Yunlu Jia and Jingjing Yang. Their work appears in journals such as Oncotarget, Biomarker Research, Biomedical Optics Express, PLoS ONE and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.